Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.48
-0.04 (-0.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Decoy Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-12.52-5.58-12.54-31.61-12.77
Upgrade
Depreciation & Amortization
0.0100.010.010.02
Upgrade
Asset Writedown & Restructuring Costs
8.52--10.85-
Upgrade
Stock-Based Compensation
0.220.270.520.80.56
Upgrade
Other Operating Activities
-0.01-0.13-0.01-0.04
Upgrade
Change in Accounts Receivable
--1.48-2.25
Upgrade
Change in Accounts Payable
-1.170.33-2.261.31-0.31
Upgrade
Change in Other Net Operating Assets
0.120.44-0.191.060.1
Upgrade
Operating Cash Flow
-4.83-4.53-12.85-17.6-10.2
Upgrade
Sale (Purchase) of Intangibles
----1.5-
Upgrade
Other Investing Activities
1.34----
Upgrade
Investing Cash Flow
0.76---1.5-
Upgrade
Short-Term Debt Repaid
-0.22-0.47-0.28--0.48
Upgrade
Total Debt Repaid
-0.22-0.47-0.28--0.48
Upgrade
Net Debt Issued (Repaid)
-0.22-0.47-0.28--0.48
Upgrade
Issuance of Common Stock
12.561.536.921.9928.77
Upgrade
Financing Cash Flow
12.341.066.641.9928.3
Upgrade
Net Cash Flow
8.28-3.47-6.21-17.1118.1
Upgrade
Free Cash Flow
-4.83-4.53-12.85-17.6-10.2
Upgrade
Free Cash Flow Margin
-----554.29%
Upgrade
Free Cash Flow Per Share
-49.78-56.44---
Upgrade
Cash Interest Paid
0.010.010.01-0
Upgrade
Levered Free Cash Flow
1.82-2.96-8.99-14.37-3.89
Upgrade
Unlevered Free Cash Flow
1.82-2.96-8.99-14.37-3.89
Upgrade
Change in Working Capital
-1.050.77-0.972.372.03
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.